Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Venous Thromboembolism 5Venous Thrombosis 4Pulmonary Embolism 4Neoplasms 4Thrombosis 2Neoplasm Metastasis 2Intracranial Thrombosis 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Multiple Myeloma 1Mesenteric Ischemia 1Lymphoma 1Hematologic Neoplasms 1

Interventions

apixaban 2Dalteparin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Intracranial Thrombosis × apixaban × Clear all
NCT03080883 2025-05-18

Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy

Academic and Community Cancer Research United

Phase 3 Completed
370 enrolled 16 charts
Other hematologic neoplasm

Neoplasm Metastasis, Pulmonary Embolism, Hematologic Neoplasms, Venous Thrombosis, Intracranial Thrombosis

NCT02585713 2020-08-04

Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism

Academic and Community Cancer Research United

Phase 3 Completed
300 enrolled 11 charts
Classical hematology

Neoplasm Metastasis, Neoplasms, Pulmonary Embolism, Venous Thrombosis, Intracranial Thrombosis, Venous Thromboembolism, Mesenteric Ischemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡